Twist Bioscience CorpTWST

TWST current price
$42.96+118.40%

Capital at risk.

1W
-2.72%
1M
-2.96%
3M
+0.89%
6M
-11.17%
1Y
+118.40%
MAX
+206.86%
About Twist Bioscience Corp
Ticker
info
TWST
Trading on
info
NASDAQ
ISIN
info
US90184D1000
Industry
info
Diagnostics & Research
Sector
info
Healthcare
CEO
info
Dr. Emily Marine Leproust Ph.D.
Headquarters
info
681 Gateway Boulevard, South San Francisco, CA, United States, 94080
Employees
info
919
Website
info
twistbioscience.com
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Metrics
BasicAdvanced
Market cap
info
$2.77B
P/E ratio
info
-
EPS
info
-$3.82
Dividend Yield
info
0.00%
Beta
info
1.78
Forward P/E ratio
info
0
EBIDTA
info
$-157M
Ex dividend date
info
-
Price & volume
Market cap
info
$2.77B
Average daily volume
info
0.6M
90-day return
info
0.89%
30-day return
info
-2.96%
7-day return
info
-2.72%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
9.01
Price to book
info
5.41
Earnings
EPS
info
-$3.82
EPS estimate (current quarter)
info
-$0.76
EPS estimate (next quarter)
info
-$0.71
EBITDA
info
$-157M
Revenues (TTM)
info
$295M
Revenues per share (TTM)
info
$5.12
Technicals
Beta
info
1.78
52-week High
info
$60.90
52-week Low
info
$18.80
50-day moving average
info
$43.69
200-day moving average
info
$42.44
Short ratio
info
14.03
Short %
info
19.68%
Management effectiveness
ROE (TTM)
info
38.36%
ROA (TTM)
info
16.39%
Profit margin
info
74.63%
Gross profit margin
info
$84.2M
Operating margin
info
54.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
27.80%
Share stats
Outstanding Shares
info
58.6M
Float
info
57.6M
Insiders %
info
2.07%
Institutions %
info
108.35%
Analyst Insights & forecasts
info

80% Buy

10% Hold

10% Sell

Based on information from 10 analysts.

Average price target

info
$53.09
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.81
-$0.92
11.96%
Q3 • 23Beat
-$0.75
-$0.78
3.85%
Q4 • 23Beat
-$0.79
-$0.82
3.66%
Q1 • 24Beat
-$1.47
-$0.77
90.91%
Q2 • 24Beat
-
-
-
Q3 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$75.3M
$-45.5M
60.41%
Q1 • 24
$81.5M
$-85.6M
105.04%
Q2 • 24
8.18%
88.10%
73.87%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$703M
$143M
20.31%
Q1 • 24
$638M
$147M
23.03%
Q2 • 24
9.21%
2.99%
13.43%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-19.4M
$-5.2M
$1.8M
$-20M
Q1 • 24
$-6.4M
$-0.7M
$2.9M
$-7.3M
Q2 • 24
67.16%
86.43%
59.08%
63.33%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Neutral

+1.5

0.25

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Twist Bioscience Corp share?
Collapse

Twist Bioscience Corp shares are currently traded for $42.96 per share.

How many shares does Twist Bioscience Corp have?
Collapse

Twist Bioscience Corp currently has 58.6M shares.

Does Twist Bioscience Corp pay dividends?
Collapse

No, Twist Bioscience Corp doesn't pay dividends.

What is Twist Bioscience Corp 52 week high?
Collapse

Twist Bioscience Corp 52 week high is $60.90.

What is Twist Bioscience Corp 52 week low?
Collapse

Twist Bioscience Corp 52 week low is $18.80.

What is the 200-day moving average of Twist Bioscience Corp?
Collapse

Twist Bioscience Corp 200-day moving average is $42.44.

Who is Twist Bioscience Corp CEO?
Collapse

The CEO of Twist Bioscience Corp is Dr. Emily Marine Leproust Ph.D..

How many employees Twist Bioscience Corp has?
Collapse

Twist Bioscience Corp has 919 employees.

What is the market cap of Twist Bioscience Corp?
Collapse

The market cap of Twist Bioscience Corp is $2.77B.

What is the P/E of Twist Bioscience Corp?
Collapse

The current P/E of Twist Bioscience Corp is null.

What is the EPS of Twist Bioscience Corp?
Collapse

The EPS of Twist Bioscience Corp is -$3.82.

What is the PEG Ratio of Twist Bioscience Corp?
Collapse

The PEG Ration of Twist Bioscience Corp is null.

What do analysts say about Twist Bioscience Corp?
Collapse

According to the analysts Twist Bioscience Corp is considered a buy.

Twist Bioscience Corp news